VEON’s Banglalink Receives Regulatory Approval to Launch Digital Payment Services to Advance Financial Inclusion in Bangladesh

VEON's Banglalink Receives Regulatory Approval to Launch Digital Payment Services to Advance Financial Inclusion in Bangladesh GlobeNewswire December 11, 2025 Dubai and Dhaka, December 11, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), today announces that Banglalink, its digital operator in Bangladesh, has received the permission of Bangladesh Bank to operate as […]

Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229

Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229 GlobeNewswire December 11, 2025 Geleen, December 11, 2025 Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that Matisse's lead compound M6229, has received the International Non-proprietary Name (INN) isupartob sodium from the World

American Hotel Income Properties REIT LP Announces CEO Change

American Hotel Income Properties REIT LP Announces CEO Change John O'Neill appointed Chief Executive Officer GlobeNewswire December 11, 2025 VANCOUVER, British Columbia, Dec. 11, 2025 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB.V) today announced that the Board of Directors has accepted the resignation of Jonathan Korol,

Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial

Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial GlobeNewswire December 11, 2025 Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune responses to personalized tumor neoantigens not present in the targeted immunotherapy 87% (13/15) of

BondBloxx Releases 2026 Fixed Income Outlook

BondBloxx Releases 2026 Fixed Income Outlook “Precision matters more than ever,” says fixed income ETF provider; points to opportunities in private credit, BB and CCC corporates, intermediate Treasuries and more GlobeNewswire December 11, 2025 LARKSPUR, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — BondBloxx Investment Management, a provider of precision fixed income ETFs with over $6

zSpace Announces Strategic Restructuring to Strengthen Financial Foundation

zSpace Announces Strategic Restructuring to Strengthen Financial Foundation GlobeNewswire December 11, 2025 SAN JOSE, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning solutions for education, today announced the successful completion of a comprehensive strategic restructuring designed to optimize its cost structure, enhance operational

Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale

SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) — In a pioneering advancement that aims to reduce the increasing problem of strokes, PT Kalbe Farma Tbk – the largest publicly listed pharmaceutical company in Southeast Asia – through its subsidiary Kalgen Innolab Clinical Laboratory (Innolab) has announced StrokeGENME, a genetics-powered platform that translates DNA insights into individualized

EB SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation Into Adequacy of Eventbrite, Inc. (NYSE:EB) Shareholder Buyout Price and Encourages Investors to Contact the Firm

Kaskela Law LLC is investigating the fairness of the recently announced buyout of Eventbrite, Inc. (NYSE: EB) shareholders to determine whether the proposed $4.50 per share buyout price undervalues the company's shares. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Click here to request additional information:https://kaskelalaw.com/case/eventbrite/ OnDecember 4, 2025, Eventbrite announced that it had agreed to be acquired by Bending Spoons at

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstDexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the

KASKELA LAW FIRM ANNOUNCEMENT: A Shareholder Class Action Lawsuit Has Been Filed Against Comerica Inc. (NYSE:CMA) – Comerica Shareholders Encouraged to Contact The Firm

PHILADELPHIA, PA / ACCESS Newswire / December 11, 2025 / The investor protection law firm of Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Comerica Inc. (NYSE:CMA) in connection with the company’s proposed acquisition by Fifth Third Bancorp. As detailed in the complaint, after an activist investor called for

Scroll to Top